PriscillaArleneHollanderMD
Endocrinology • Dallas, TXDiabetes, Lipid Metabolism
Endocrinologist, Baylor Endocrine Center
Dr. Hollander is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3600 Gaston Ave
Suite 656
Dallas, TX 75246Phone+1 214-820-3466Fax+1 214-820-3468
Education & Training
University of WashingtonFellowship, Endocrinology, Diabetes, and Metabolism, 1978 - 1980
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1974 - 1977
Harvard Medical SchoolClass of 1974
Certifications & Licensure
TX State Medical License 1977 - 2025
MN State Medical License 1980 - 2011- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Super Doctor SuperDoctors.com
Clinical Trials
- A Safety and Efficacy Study Comparing Naltrexone SR/Bupropion SR and Placebo in Obese Subjects With Type 2 Diabetes Start of enrollment: 2007 May 01
- A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes Start of enrollment: 2013 May 01
- Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients Start of enrollment: 2015 Aug 01
Publications & Presentations
PubMed
- 285 citationsEffects of naltrexone sustained-release/bupropion sustained-release combination therapy on body weight and glycemic parameters in overweight and obese patients with ty...Priscilla Hollander, Alok Gupta, Raymond A Plodkowski, Frank L. Greenway, Harold Bays
Diabetes Care. 2013-12-01 - 424 citationsRole of Orlistat in the Treatment of Obese Patients With Type 2 Diabetes: A 1-year randomized double-blind studyPriscilla Hollander, Steven C. Elbein, Irl B. Hirsch, David E. Kelley, Janet B. McGill
Diabetes Care. 1998-08-01 - 189 citationsEffect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin.John M. Miles, Lawrence Leiter, Priscilla Hollander, Thomas Wadden, James W. Anderson
Diabetes Care. 2002-07-01
Press Mentions
SGLT2 Inhibitor Adds to Weight Loss with PhentermineJune 16th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
